Lemme Lose It: The Marketing Behind GLP-1

Zuryna: Hey friends, welcome back
to operations unfiltered the podcast

that takes you behind the scenes of
influencer and talent management.

I'm your host Zarina and I'm episodes
when I'm not joined by a special guest.

I like to do a deep dive into
topics that caught my attention.

But through the lens of project
management today, we're talking all

things, marketing operations for GLP one
supplements, specifically, we'll take

a closer look at Courtney Kardashian
Barker's latest wellness venture

with Lemmy GLP one daily supplements.

Then we're going to explore the pros
and cons of marketing over the counter

supplements versus FDA approved options
and what that means for the influencer

and content creator community.

So without further ado, let's
get into this week's episode

of operations unfiltered.

If you're like me and your guilty
pleasure is watching the Kardashians,

then you know that health conscious
Eldest Kardashian Kourtney is co owner

of vitamin and supplement brand Lemmy.

I've tried a few products, and I
have to say they taste pretty good.

They don't have that chalky
aftertaste like some of the

other supplements I've tried.

With the influx of health conscious
consumers, it looks like Mrs.

Kardashian Barker is tapping into
the GLP 1 receptor agonist market.

With the extreme success of other
Kardashian brands that are typically

in the lifestyle and fashion space,
I wonder if the Lemmy GLP 1 Daily

Supplements is gonna have the same
stellar success as her other brands.

Surprisingly enough, I was watching
the Today Show one morning and

there was a segment on about
the popularity of supplements.

Supplement brands.

Of course, Lemmy was
named, and a few others.

And that's when the aha
moment happened for me.

I realized that it's the Kourtney
Kardashian or Kardashian Barker effect.

That's when a celebrity with
Kourtney's reach backs a product and

it instantly gains a built in audience.

Her followers trust her recommendations,
especially in wellness where she's built

an image of being health conscious.

And if you've watched the Kardashians
on Hulu, then you know how serious

she is about her kids not eating sugar
and just living a well balanced life.

The fact that supplements, unlike
pharmaceuticals, can be purchased over the

counter or online without a prescription.

It's a marketing operations dream.

From that perspective, this opens up
endless opportunities to engage with

customers directly through influencer
marketing, social media campaigns,

and personalized advertising.

Especially since GLP one supplements
are being marketed as convenient

natural alternative to those more
medically regulated solutions like

the will go V's that bound, etc.

So with that in mind, I got to
thinking, what are some of the pros

and cons of marketing these supplements
versus the FDA approved treatments?

Of course, supplements
can hit the market faster.

They have less regulatory oversight
and that speed allows companies to

stay ahead of trends and rapidly
respond to consumer demands.

For example, if the flavor is off
or if products are moldy quickly,

they can definitely react quicker.

From a marketing standpoint, this
means shorter product development

cycles and more flexibility in
how you market the benefits.

But because they aren't regulated
like pharmaceuticals, supplements

can't make specific medical claims.

Did you guys know that?

I had no idea you couldn't make specific
medical claims you can't advertise

a supplement as a direct treatment
for obesity, metabolic syndrome, or

diabetes the way you can with FDA
approved GLP 1 drugs like Zet Bound, etc.

So of course, if you're marketing
LEMI products, for example, there's

this gray area where you rely on
vague terms like support metabolism

or promotes weight management, curbs
your appetite, things like that.

Another challenge is trust.

Of course, we love celebrity
endorsements and they can boost

credibilities, but we're not stupid.

We're very savvy and we're
cautious about health claims.

I know a lot of people who
personally prefer FDA approved items

simply because they have rigorous
testing for safety and efficacy.

GLP 1 agonists like Ozempic and Wegovy
have gone through that process and they

can make those specific claims about
weight loss and glucose control, whereas

products like LEMI and other things
simply can't make , those promises.

But on the other hand, some
people don't trust the FDA either.

So from a marketing perspective, it's
like my grandma always says six eggs

in one hand, half a dozen in the other.

Sorry, that might be a little too
Southern for some of my listeners.

My apologies.

So what does this mean for the
future of marketing operations in

the wellness and supplement space?

From my research and experience
for supplement marketers, it's all

about walking that fine line between
creating buzz, but staying compliant,

making sure you're not over promising.

That means relying on influencer
marketing, wellness narratives,

and personal testimonies.

Building trust is key, but it's
important to educate consumers.

Without over promising.

And of course, for FDA approved
products, in my opinion, the

challenge is differentiation.

How can you, Ozempic, stand out in
such a highly regulated space while

maintaining the trust that comes
along with that stamp of approval?

That's where things like patient
outcomes, clinical studies, and

of course, healthcare professional
endorsements come into play.

So maybe they need to get Dr.

Now to advertise that he's for
Wegovy or something like that.

It could help.

At the end of the day, marketing
operations for supplements like

Kourtney Kardashian Barker's Lemme
brand thrive on fast execution,

creativity, and influencer power.

But, the trade off is the lack of
regulatory backing and consumer trust

that sometimes comes with FDA approval

what are your thoughts?

Thank you for tuning into this week's
episode of Operations Unfiltered.

If you enjoyed this breakdown, make sure
to subscribe and I'll see you next time.

Lemme Lose It: The Marketing Behind GLP-1
Broadcast by